Michael Angastiniotis
- Genetics top 1%
- Hemoglobinopathies and Related Disorders 35
- Genomics and Rare Diseases 2
- Hematology top 1%
- Iron Metabolism and Disorders 21
- Blood groups and transfusion 3
-
- Prenatal Screening and Diagnostics 6
- Pharmacological Effects and Toxicity Studies 2
-
- Cystic Fibrosis Research Advances 3
- Neonatal Respiratory Health Research 2
- Co-authors
- Androulla EleftheriouDimitrios FarmakisStephan LobitzJohn B. PorterSoteroula ChristouNicos SkordisMaria Domenica CappelliniAlì Taher
- Journals
- SHILAP Revista de lepidopterología (4 papers)Brain Research (1 paper)Annals of the New York Academy of Sciences (1 paper)
- Partner nations
- CyprusUnited KingdomGreece
In The Last Decade
Michael Angastiniotis
41 papers receiving 891 citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Genetics 805
- Hematology 675
- Pediatrics, Perinatology and Child Health 224
- Nutrition and Dietetics 58
- Management of Technology and Innovation 24
Countries citing papers authored by Michael Angastiniotis
This map shows the geographic impact of Michael Angastiniotis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Angastiniotis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Angastiniotis more than expected).
Fields of papers citing papers by Michael Angastiniotis
This network shows the impact of papers produced by Michael Angastiniotis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Angastiniotis. The network helps show where Michael Angastiniotis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Angastiniotis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 1 | |
| 8 | 2014 | 66 | |
| 9 | 2014 | 5 | |
| 10 | 2013 | 120 | |
| 11 | 2013 | 46 | |
| 12 | 2013 | 13 | |
| 13 | 2012 | 3 | |
| 14 | International network on endocrine complications in thalassaemia (I-CET): an opportunity to grow. | 2012 | 6 |
| 15 | 2009 | 3 | |
| 16 | Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004. | 2006 | 145 |
| 17 | PREVENTION AND CONTROL OF HEMOGLOBINOPATHIES | 1995 | 3 |
| 18 | 1994 | 2 | |
| 19 | Management of thalassemia in Cyprus. | 1992 | 6 |
| 20 | 1992 | 2 |
About Michael Angastiniotis
Michael Angastiniotis is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health, having authored 46 papers that have together received 950 indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (35 papers), Iron Metabolism and Disorders (21 papers), Prenatal Screening and Diagnostics (6 papers), Cystic Fibrosis Research Advances (3 papers), Blood groups and transfusion (3 papers), Genomics and Rare Diseases (2 papers), Neonatal Respiratory Health Research (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Genetics (805 citations), Hematology (675 citations) and Pediatrics, Perinatology and Child Health (224 citations). Michael Angastiniotis has collaborated with scholars based in Cyprus, United Kingdom and Greece. Frequent co-authors include Androulla Eleftheriou, Dimitrios Farmakis, Stephan Lobitz, John B. Porter, Soteroula Christou, Nicos Skordis, Maria Domenica Cappellini, Alì Taher, Béatrice Gulbis and Joan‐Lluís Vives Corrons. Their work appears in journals such as SHILAP Revista de lepidopterología, Brain Research and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.